Literature DB >> 29547708

Resolution of fatty liver and weight loss: Independent associations with changes in serum lipids and apolipoproteins.

Ki-Chul Sung1, Mi-Yeon Lee2, Jong-Young Lee3, Sung-Ho Lee3, Jang-Young Kim4, Sarah H Wild5, Christopher D Byrne6.   

Abstract

BACKGROUND AND AIMS: It is uncertain whether resolution of fatty liver can improve cardiovascular disease risk factors, independently of changes in body mass index (BMI). Our aim was to test whether resolution of fatty liver is associated with improvements in components of the lipid profile, independently of changes in BMI, and to quantify and compare the magnitude of benefit of resolution of liver fat, and decreases in BMI on the lipid profile.
METHODS: 36,195 subjects with fatty liver were studied. Persistence/resolution of fatty liver was determined by ultrasound at follow up (mean = 4.93 years). Total cholesterol, triglycerides, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and apolipoproteins were measured at baseline and follow up. Regression modelling was undertaken to test the independence of associations between change in fatty liver status or change in BMI, with any change in lipid profile concentrations between baseline and follow up.
RESULTS: Mean (SD) age was 36.3 ± 6.6 and 39.8 ± 8.7 years (men and women, respectively). Resolution of fatty liver occurred in 7,086, and persisted in 29,109 subjects. Mean ± SD weight change was -3.2 ± 4.3 (∼1 kg/m2 decrease in BMI) with resolution of, and +0.5 ± 3.5 kg with persistence of fatty liver, respectively. Both resolution of fatty liver and decrease in BMI were independently associated with improvements in all components of the lipid profile and there was a similar magnitude of benefit associated with resolution of fatty liver, or 1 kg/m2 decrease in BMI.
CONCLUSIONS: Resolution of fatty liver improves the lipid profile, independently of weight loss.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  BMI; Fatty liver; Insulin resistance; Lipid; Metabolic syndrome; Non-alcoholic fatty liver disease; Obesity

Mesh:

Substances:

Year:  2018        PMID: 29547708     DOI: 10.1016/j.atherosclerosis.2018.03.018

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  2 in total

1.  Lipoprotein Subclass Profile after Progressive Energy Deficits Induced by Calorie Restriction or Exercise.

Authors:  Yu Chung Chooi; Cherlyn Ding; Zhiling Chan; Jezebel Lo; John Choo; Benjamin T K Ding; Melvin K-S Leow; Faidon Magkos
Journal:  Nutrients       Date:  2018-11-21       Impact factor: 5.717

2.  The Repeatedly Elevated Fatty Liver Index Is Associated With Increased Mortality: A Population-Based Cohort Study.

Authors:  Chang-Hoon Lee; Kyung-Do Han; Da Hye Kim; Min-Sun Kwak
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-12       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.